Atlas Trials

A Study of the Absorption, Metabolism, and Excretion of [14C]-Brensocatib Following a Single Oral Administration in Healthy Male Participants

Clinical trial NCT05652257 · COMPLETED

Trial details

NCT number
NCT05652257
Sponsor
Insmed Incorporated
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Volunteers
Start date
2021-08-13
Primary completion
2021-09-14
Enrollment
7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.